Programme

Actual aspects of diagnostic and treatment of pituitary diseases.
The event will be held in a hybrid format. The programme includes sponsored lectures

25 February 2022 / Friday

 

14:20 - 14:30 (CET)
Opening ceremony

Session I
14:30 - 15:55 (CET)
Aggressive pituitary tumours  (85 minutes)

• 14:30 - 14:55 (CET)
  Aggressive pituitary tumours –how to diagnose and proceed 
  Prof. Gerald Raverot 
   
• 14:55 - 15:20 (CET)
  Genetics of Cushing's Disease
  Prof. Marta Korbonits
   
• 15:20 - 15:45 (CET)
  Aggressive non-functioning pituitary tumours 
  Prof. Niki Karavitaki
   
• 15:45 - 15:55 (CET)
  Q & A  Discussion
  
  

Expert lecture of the National Consultant in Endocrinology 

15:55 - 16:15

National Program of Growth Hormone Deficiency Treatment in Adults Prof. Andrzej Lewiński

 

Session II
16:15 - 17:15 (CET)
Treatment with Growth Hormone in the transition age for young adults and adult patients (60 minutes)

• Modyfikacja leczenia substytucyjnego w okresie dorastania/ u młodych dorosłych Dr hab. Małgorzata Wójcik
• Powikłania metaboliczne i zasady farmakoterapii u pacjentów z niedoczynnością przysadki  Dr hab. Anna Popławska-Kita 
• Practical aspects and experiences in qualification and treatment of patients for National Program of Growth Hormone Deficiency Treatment in Adults Dr hab. Renata Stawerska
• Q&A- Discussion
   

 

Session III
17:15 - 18:55 (CET)
Diagnostic standards and treatment of acromegaly (100 minutes)

 

• Current acromegaly management guidelines Prof. Alicja Hubalewska-Dydejczyk 
• What we know about acromegaly in Poland? Prof. Wojciech Zgliczyński
• Acromegaly complications - The diagnosis and treatment  Prof. Marek Ruchała
• Improvement of quality of life in patients with acromegaly during treatment Prof. Marek Bolanowski
• Management of patients with aggressive tumours in acromegaly Dr hab. Aleksandra Gilis-Januszewska, Prof. UJ 
• Q&A- Discussion
   

 

Session IV
18:55 - 19:35 (CET)
Acromegaly- presentation of challenging cases (40 minutes)

• TBA
• Silent GH Magdalena Godlewska, MD
• Young Onset Acromegaly TBA
• Long-term experience of Somnavert as a treamtet of acomegaly Jacek Pantofliński, MD, PhD
• Q&A- Discussion

 

 

26 February 2022 / Saturday

Session V
9:00 - 10:40 (CET)
Cushing syndrome - Diagnostic standards and treatment (100 minutes)

 

• The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing syndrome Prof. Grzegorz Zieliński
• The diagnosis of Cushing syndrome - current Pituitary Society guidelines Dr hab. A.Gilis-Januszewska Prof. UJ
• Management of arterial hypertension in Cushing disease  Prof. Przemysław Witek
• Thromboembolic complication in hypercortisolism Joanna Zdziarska, MD, PhD
• Cyclical Cushing syndrome Dr hab. Renata Świątkowska-Stodulska
• Q&A- Discussion

 

 

Session VI
10:40 - 11:20 (CET)
Cushing syndrome - cases presentation (40 minutes)

• Pituitary carcinoma and liver metastases in a patient with Cushing disease Maria Stelmachowska-Banaś, Md, PhD
• Temozolomide and pasireotide treatment in a patient with aggressive silent corticotrophinoma Anna Bogusławska, MD
• Young patient with Cushing disease and glucocorticoids resistance Ewa Obel, MD, PhD
• Q&A- Discussion

 

 

Session VII
11:20 - 13:00 (CET)
Craniopharyngioma in children and adults (100 minutes)

• Craniopharyngioma in children Prof. Jerzy Starzyk
• Craniopharyngioma in adults Łukasz Kluczyński MD, PhD
• Surgical management of craniopharyngioma Borys Kwinta MD, PhD
• Metabolic complications - pharmacologic treatment of obesity Prof. Beata Matyjaszek-Matuszek
• Obesity treatment in patients with craniopharyngioma Prof. Piotr Major 
• TBA  Bartosz Partyński MD
• Q&A- Discussion

 

13.00 - 15.00 (CET) Lunch

 

Session VIII
15:30 - 16:30 (CET)
he genetics of pituitary tumours. Presentation of challenging cases (60 minutes)

• McCune-Albright syndrome Prof. Katarzyna Ziemnicka 
• Carney complex Maria Stelmachowska-Banaś, MD, PhD
• Pituitary adenoma and pheochromocytoma/paraganglioma association. Heterogeneity of clinical course of the disease with various genetic mutations  Ewelina Rzepka MD
• MEN1/MEN4 Anna Bogusławska, MD
• Q&A- Discussion

 

Session IX
16:30 - 17:50 (CET)
Perioperative management of patients with pituitary tumours (80 minutes)

• Diagnostic and treatment of diabetes insipidus Prof. Anhelli Syrenicz
• Management of perioperative electrolyte imbalance Dr hab. Dariusz Kajdaniuk
• Treatment of central hypothyroidism in a challenging cases Prof. Alicja Hubalewska-Dydejczyk
• Treatment of insufficiency of pituitary adrenal axis is an art Prof. Tomasz Bednarczuk